14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CUE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Monday for Cue Biopharma Inc.
(Updated on Apr 22, 2024)

Sell candidate since Apr 09, 2024 Loss -17.37% PDF

The Cue Biopharma Inc. stock price gained 0.641% on the last trading day (Monday, 22nd Apr 2024), rising from $1.56 to $1.57. During the last trading day the stock fluctuated 6.04% from a day low at $1.49 to a day high of $1.58. The price has fallen in 8 of the last 10 days and is down by -23.04% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 14 thousand more shares were traded than the day before. In total, 181 thousand shares were bought and sold for approximately $284.57 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -35.82% during the next 3 months and, with a 90% probability hold a price between $0.92 and $1.20 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CUE Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 5.02%. Further rise is indicated until a new top pivot has been found. Cue Biopharma Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cue Biopharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.60 and $1.85. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cue Biopharma Inc. stock

Cue Biopharma Inc. finds support from accumulated volume at $1.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0900 between high and low, or 6.04%. For the last week, the stock has had daily average volatility of 8.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CUE) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Cue Biopharma Inc. to open at $1.55, and during the day (based on 14 day Average True Range), to move between $1.42 and $1.72, which gives a possible trading interval of +/-$0.147 (+/-9.39%) up or down from last closing price. If Cue Biopharma Inc. takes out the full calculated possible swing range there will be an estimated 18.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.56 (0.64%) than the resistance at $1.76 (12.10%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cue Biopharma Inc. stock A Buy?

Cue Biopharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.808 Sell Candidate Unchanged

Predicted Opening Price for Cue Biopharma Inc. of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$1.55 ( 1.49%) $1.57

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CUE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.64 4.25 %
R2 1.60 2.06 %
R1 1.58 0.704 %
Current price: 1.57
Support S1 1.51 -3.68 %
S2 1.49 -5.03 %
S3 1.46 -7.22 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.90 21.02 %
R2 1.77 12.74 %
R1 1.76 12.10 %
Current price 1.57
Support S1 1.56 -0.637%
S2 1.50 -4.78%
S3 0 .

FAQ

What is the symbol for Cue Biopharma Inc. Stock and on which exchange is it traded?
The symbol for Cue Biopharma Inc. is CUE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cue Biopharma Inc. Stock?
Cue Biopharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cue Biopharma Inc. Stock?
Cue Biopharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cue Biopharma Inc. Stock.

What's the current price of Cue Biopharma Inc. Stock?
As of the end of day on the Apr 22, 2024, the price of an Cue Biopharma Inc. (CUE) share was $1.57.

What is the 52-week high and low for Cue Biopharma Inc. Stock?
The 52-week high for Cue Biopharma Inc. Stock is $5.12 and the 52-week low is $1.47.

What is the market capitalization of Cue Biopharma Inc. Stock?
As of the Apr 22, 2024, the market capitalization of Cue Biopharma Inc. is 76.37M.

When is the next earnings date for Cue Biopharma Inc.?
The upcoming earnings date for Cue Biopharma Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Cue Biopharma Inc.

Cue Biopharma. Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-10... CUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT